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Elements: Can We Predict the
Protein Output from an
Alternatively Spliced Locus?
Alternative splicing choices are governed by splicing
regulatory protein interactions with splicing silencer
and enhancer elements present in the pre-mRNA.
However, the prediction of these choices from geno-
mic sequence is difficult, in part because the regula-
tors can act as either enhancers or silencers. A recent
study describes how for a particular neuronal splicing
regulatory protein, Nova, the location of its binding
sites is highly predictive of the protein’s effect on an
exon’s splicing.
In eukaryotic cells, the formation of a mature mRNA re-
quires the removal of introns from the precursor mRNA
and splicing of its exons. This is a key step in determin-
ing the protein output from a gene. Alternative splicing
allows joining of exons in different patterns, enabling a
single gene to produce multiple protein isoforms (Black,
2003). This form of regulation is particularly common in
the mammalian nervous system where a large percent-
age (40%–60%) of neuronal pre-mRNAs undergo alter-
native splicing (Yeo et al., 2004). Many of these splicing
events produce proteins important for neuronal devel-
opment (e.g. neurexins, EphA7) and mature neuronal
function (e.g. NMDA receptor 1, CaV2), and changes in
the splicing of their pre-mRNAs result in multiple func-
tional variants (Lipscombe, 2005). A long-term goal of
genomic research is the prediction of the protein prod-
ucts of a gene under different cellular conditions. How-
ever, the frequency with which gene transcripts show al-
ternative splicing in the nervous system and the large
number of potential products from some of these genes
make this prediction extremely difficult.
The information that determines an alternative splic-
ing pattern is usually encoded within the sequence of
a regulated exon and its flanking introns in the form of
intronic or exonic splicing silencer elements (ISS or
ESS) and intronic or exonic splicing enhancer elements
(ISE or ESE). Enhancer elements promote the inclusion
of an exon, and silencers promote its skipping or exclu-
sion from the final mRNA. Many of these elements are
bound by known RNA-binding proteins (RBPs), suchas the SR proteins and members of the hnRNP group
of proteins (Black, 2003). Many more elements have
been identified, but their protein mediators are un-
known. Most alternative exons are controlled by multi-
ple splicing enhancer and silencer elements. Moreover,
many elements are not strict silencers or enhancers,
rather the position of an element relative to an alterna-
tive exon can determine whether it acts positively or
negatively (Hui et al., 2005). We need to know much
more about the rules that determine the positive or neg-
ative activity of these regulatory elements. What is the
code for exon use? What are the mechanisms by which
these elements act on the splicing apparatus? A recent
paper in Nature shows for one splicing regulator that
such a code exists and can successfully predict the reg-
ulatory properties of the exon targets for this protein
(Ule et al., 2006). Moreover, this paper and recent
work from others have started to identify the specific
steps in spliceosome assembly affected by a regulatory
protein.
Genomic analyses of alternative splicing indicate that
the brain has the highest frequency of alternative splic-
ing (Sugnet et al., 2006; Yeo et al., 2004). The neuron-
specific inclusion or skipping of alternative exons is
primarily achieved by tissue-specific expression of par-
ticular RBPs (Matlin et al., 2005). Over a dozen neuron-
specific RBPs have been identified, including the Hu
family, members of the CELF family, neural PTB, the
Fox protein family, and Nova—the subject of the Nature
paper (McKee et al., 2005; Ule et al., 2006). These regu-
lators affect a wide range of target gene transcripts, en-
coding proteins involved in cytoskeletal rearrangement,
vesicular transport, cell adhesion, signal transduction
pathways, and synaptic activity (Lipscombe, 2005). In
earlier work, the Darnell lab identified Nova protein as
a YCAY element binding factor. They went on to use a va-
riety of biochemical, genomic, and genetic approaches
to identify a large number of exons in genes affecting
synaptic function whose splicing was affected by Nova
(Ule et al., 2006, and references therein).
The known Nova-regulated exons showed a variety of
dependencies, some enhanced by the protein and
others repressed. In the present study, the authors car-
ried out statistical analyses of the positions of YCAY
clusters relative to the known Nova target exons (Ule
et al., 2006). They noted the positions of these clusters
relative to the target exon and created a general map
relating the frequency of YCAY clusters surrounding
Nova-regulated exons. These clusters fall into relatively
few defined positions upstream, downstream, or within
the exon (Figure 1). Interestingly, certain positions
strongly correlate with splicing enhancement by Nova,
while other positions correlate with Nova acting to re-
press splicing. The authors tested the predictive value
of the map by searching a genomic database for addi-
tional YCAY cluster-containing exons that had not
been previously identified as Nova targets. The splicing
of these exons was compared in wild-type and Nova
knockout mice. They found that the positions of Nova-
dependent enhancers and silencers indicated by the
map were strongly predictive of the changes observed
between the presence and absence of Nova. This both
validated the value of the Nova RNA map and identified
a new set of Nova target exons.
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been shown to affect their activity as enhancers or si-
lencers. This has been best studied for the SR proteins,
which enhance splicing when bound in an exon but are
inhibitory as intron-binding proteins (Ibrahim el et al.,
2005). HnRNPs H and L seem to repress splicing
when bound in an exon, but activate it from the intron
downstream (Black, 2003; House and Lynch, 2006;
Hui et al., 2005). Fox proteins bound upstream of an
exon repress its splicing, whereas downstream Fox
binding enhances it (Jin et al., 2003). The Nova results
also fit with genome-wide analyses that most splicing
regulatory elements lie in the vicinity of 50 and 30 splice
sites, or upstream of the branch point (Sugnet et al.,
2006, and references therein). Nova enhancer elements
are intronic, most commonly in the intron downstream
of the regulated exon, but some are upstream. Nova si-
lencer elements, on the other hand, are either within the
regulated exon or close to the 50 splice site of the up-
stream intron (Figure 1). What is new in the Ule paper
is the precise definition of the regions where YCAY clus-
ters can act and their clear predictive power for identify-
ing Nova-regulated exons and their positive or negative
response. It is likely that similar predictive maps can be
generated for other splicing elements and their regula-
tory factors.
All major class introns are excised by a dynamic mac-
romolecular complex called the spliceosome (Will and
Luhrmann, 2006). The spliceosome assembles through
the sequential binding of five small nuclear ribonucleo-
protein particles (snRNPs) and multiple auxiliary pro-
teins. The ordered association of the snRNPs and pro-
teins with the target intron leads to the formation of
discrete intermediate complexes (Figure 2A). During
this assembly, the two splice sites are recognized by
specific components, brought into close juxtaposition,
and ultimately subjected to the two catalytic reactions
that result in intron excision and exon ligation (Figures
2A and 2B). The stepwise nature of spliceosome assem-
bly provides multiple potential points at which it can be
regulated. Indeed, different regulatory proteins have
been shown to affect different steps in spliceosome as-
sembly (Black, 2003, and references therein). Splicing
repressors can act by directly blocking the binding of
spliceosomal components with the pre-mRNA, by
blocking the interaction of splicing enhancers with the
basal splicing machinery, or by blocking the transition
from one stage of spliceosome assembly to the next
(House and Lynch, 2006; Izquierdo et al., 2005; Sharma
et al., 2005). In each case, the interactions of the repres-
sor protein with basal splicing components can lead to
Figure 1. The Nova Binding Site Map Shows that the Position of
YCAY Clusters Can Be Correlated with Their Effect on Alternative
Splicingexon skipping. To examine the mechanism by which
Nova repressed exon inclusion, Ule and colleagues ex-
amined spliceosome assembly for an RNA containing
an inhibitory YCAY cluster within the regulated exon.
Splicing complex analysis on this RNA indicated that
Nova blocked assembly of the E complex and more spe-
cifically the association of the U1 snRNP with the 50
splice site (see Figure 2A for the specifics of spliceo-
some assembly). This is different from splicing repres-
sors, such as PTB and hnRNP L, which generally do
not block the initial binding of snRNPs or other basal
components, but instead interfere with their interactions
within subsequent prespliceosome complexes. In light
of the diverse nature of the Nova silencer and enhancer
elements, it is likely that they will use additional mecha-
nisms to alter spliceosome assembly beyond the one
identified by Ule et al.
To examine Nova function in vivo, the authors also ex-
amine the partially spliced RNA surrounding Nova-
dependent exons in wild-type and Nova knockout
mice. Using RT/PCR to amplify RNAs where either the
upstream or the downstream intron has been excised,
but not the other, they find the build up or decrease of
only one of the partially spliced RNAs in the Nova knock-
out mice. For intronic YCAY clusters, Nova affects the
extent of splicing of the YCAY-containing intron, and
not the opposite intron across the regulated exon. If
the YCAY cluster is exonic, Nova affects the removal
of the more proximal intron. This agrees with the ob-
served effect on U1 binding for the in vitro experiments
but also indicates that Nova likely affects other factors
when the binding site is not adjacent to the 50 splice
Figure 2. Pre-mRNA Splicing Is Catalyzed by the Spliceosome
(A) The spliceosome assembles from five snRNPs, referred to as U1,
U2, U4, U5, and U6, and auxiliary proteins. The multiple steps in this
assembly lead to the formation of distinct H, E, A, B, and C
complexes.
(B) The E complex has the U1 snRNP bound to the 50 splice site and
the SF1 and U2AF proteins bound to the BP and polypyrimidine
tract, respectively. Splicing regulatory proteins interfere with the
binding of core components of the splicing machinery or prevent
transitions between spliceosome assembly intermediates.
Neuron
576site. Moreover, most tissue-specific exons are regulated
by multiple positive and negative factors. When Nova is
absent, these exons may be more strongly affected by
other factors than is normally seen. Thus, it is not clear
whether there will be a general rule for the order of intron
removal.
A long-term goal of genomics is to predict the tissue-
specific expression of each protein encoded within a
genome. The prevalence of alternative splicing in the
mammalian nervous system and the diverse factors
controlling it make this much more difficult. However,
the success of the Ule study in predicting Nova regula-
tion from the global mapping of its binding sites is a
very promising step forward and can be usefully applied
to other splicing regulators. With these maps in hand, we
can begin the even more daunting task of examining
how the splicing apparatus can integrate the multiple
positive and negative inputs for each exon.
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